Bio Path | BPTH - Equity Capital And Reserves


Bio Path reported $-8M in Equity Capital and Reserves for its fiscal quarter ending in September of 2025.





Equity Capital And Reserves Change Date
Alterity Therapeutics Limited AUD 36.21M 18.58M Dec/2025
Baxter International USD 6.13B 1.11B Dec/2025
Bio Path USD -8M 846K Sep/2025
Cipla INR 329.19B 16.3B Sep/2025
Clal Biotechnology ILS 121.41M 4.62M Dec/2023
Compugen USD 102.73M 58.9M Dec/2025
CSL USD 18.66B 2.75B Dec/2025
Grifols EUR 6.21B 133.12M Dec/2025
Karyopharm Therapeutics USD -292.93M 23.67M Dec/2025